In Vitro Interleukin-3 Binding to Leukemia Cells Predicts Cytotoxicity of a Diphtheria Toxin/IL-3 Fusion Protein-Reference-Cited by-同舟云学术

In Vitro Interleukin-3 Binding to Leukemia Cells Predicts Cytotoxicity of a Diphtheria Toxin/IL-3 Fusion Protein

Published:2000-06-16 Issue:4 Volume:11 Page:564-568
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Alexander R. L.¹,Kucera G. L.¹,Klein B.¹,Frankel A. E.¹

Affiliation:

1. Department of Physiology and Pharmacology, Department of Internal Medicine, Section on Hematology/Oncology, and Department of Cancer Biology, Wake Forest University School of Medicine, Wake Forest, North Carolina 27157, and Monsanto Company, St. Louis, Missouri

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc000009q

Reference35 articles.

1. MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm;Blood Advances;2020-08-25

2. Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm;Expert Review of Clinical Pharmacology;2019-10-01

3. The interleukin-3 receptor CD123 targeted SL-401 mediates potent cytotoxic activity against CD34+CD123+ cells from acute myeloid leukemia/myelodysplastic syndrome patients and healthy donors;Haematologica;2018-05-17

4. CD123 and its potential clinical application in leukemias;Life Sciences;2015-02

5. Adjusting transgene expression levels in lymphocytes with a set of inducible promoters;The Journal of Gene Medicine;2010-05-18